Clinical trials
Phase 3 Urinary Bladder, Overactive trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Christopher Patrick Smith | 1 |
| Herlev and Gentofte Hospital | 1 |
| Lanzhou Institute of Biological Products Co., Ltd | 1 |
| Medy-Tox | 1 |
| Seoul National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder, Overactive | 5 |
| Urinary Incontinence | 2 |
| Hematuria | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Spinal Cord Injuries | 1 |
| Urinary Incontinence, Urge | 1 |
| Urinary Tract Infections | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.